• br Liposomes recovered from plasma were separated

  2019-10-29

  

  Liposomes recovered from plasma were separated form excess plasma proteins by size exclusion chromatography followed by mem-brane ultrafiltration as we have previously described [10–12]. 4.6. Size and zeta potential measurements using dynamic light scattering (DLS) Liposome size and surface

• br Running time for the best solution br Feature

  2019-10-21

  

  6.4.4. Running time for the best solution Feature selection approaches can decrease the dimensional of feature space and reduce the computational complexity. Furthermore, it BQ-788 sodium salt can reduce the running time for the classification models. As can be observed in Figs. 8 and 9, we can

• br Keywords br Gastric cancer br RUNX br

  2019-10-21

  

  Keywords: Gastric cancer RUNX1 In the present study, two circular RNA (circRNA) expression profiles in paired gastric cancer (GC) tissues from the GEO database were examined. We identified a novel circRNA, has_circ_0001461, which we termed circFAT1(e2). We verified that circFAT1(e2) was s

• br refine imaging techniques to confirm

  2019-10-21

  

  refine imaging techniques, to confirm deep tissue imaging in ortho-topic and metastatic models, and to delineate comparisons of SPECT with PET. It will be interesting to investigate in future experiments whether radioiodine uptake correlates to viral tumor titer throughout all time points and to f

• br Network based methylation NBM score of EC gene further

  2019-10-16

  

  3.2.2. Network based methylation (NBM) score of EC gene further improves classification accuracy Since many ECs do not show methylation changes between the re-current and non-recurrent tumors, they may have played a role through their interactions with the DMs, for example, DNA methylation change

• br Apparent performance of the nomogram in

  2019-10-15

  

  2.6. Apparent performance of the nomogram in the training dataset and validation dataset Calibration curves were plotted to assess the calibration of the predictive nomogram [21]. Calibration was assessed by plotting the predicted versus the actual probability for quintiles of the predicted pro

• br Activated mature DCs were harvested

  2019-10-15

  

  Activated mature DCs were harvested on day 9 by careful pipetting and collected in 50 mL centrifuge tubes for counting and phenotypic analysis using flow cytometry. Aliquots of generated DCs (Loaded DCs and unloaded DCs) were directly stained using fluorescent conjugated mouse monoclonal MPP+ Iodi

• br of CD or vWF positive areas

  2019-10-14

  

  of CD31- or vWF-positive areas per field was markedly decreased in the tumor tissues treated with oxaliplatin or CPT-11 alone, and in combi-nation with BP10A (Fig. 6C). These data suggest that BP10A also sy-nergistically suppress the progression of angiogenesis with anti-cancer drugs for CRC. It h

• br Results br Furthermore URO were also more likely to

  2019-10-14

  

  Results .05). Furthermore, URO were also more likely to practice in a community-based clinic, receive reimbursement by a billing compensation structure, and have access to robot-assisted surgery compared to RO from the survey sample (all P Overall, 57.8% of all respondents also reported havin

• br MRI Interpretation br Readers were

  2019-10-14

  

  MRI Interpretation Readers were instructed to use RadiAnt DICOM Viewer to view images (14). All 135 sequences were randomized per reader and provided in this order with a read-out form designed with Microsoft Access (15). Within this programmed form, shown in Figure 2, readers recorded up to fo

• br Inclusion of criteria and subcriteria br We first

  2019-10-10

  

  3.3.1. Inclusion of criteria and subcriteria We first determined the goal of the decision making, which is selecting the best treatment for breast cancer, and according to this 4μ8C goal we selected the criteria and subcriteria that have an effect in the decision making process [26]. We define

• br Endpoints br The following toxicity endpoints were define

  2019-10-09

  

  Endpoints The following toxicity endpoints were defined at 6 months from treatment completion: (1) dysphagia grade 2; (2) dysphagia grade 3; (3) xerostomia grade 2; (4) salivary duct AR-13324 grade 2; and (5) tube feeding depen-dence. Salivary duct inflammation toxicity was graded as such: gra

• ITF2357 (Givinostat) br The PRAD expression data sets were d

  2019-10-08

  

  The PRAD ITF2357 (Givinostat) data sets were downloaded from the TCGA data portal. The RPM of miRNAs and the FPKM of mRNAs were normalized before our analysis. Similarly with the NEST, we estimated the essenti-ality of a node as the weight by summing of the expression level of its neighbors and i

• br MYD and TRIF were inhibited

  2019-10-08

  

  MYD88 and TRIF, were inhibited, which could exacerbate HPV infection. Third, we found that ectopic Herboxidiene of YAPS127A in- hibited the expression and activation of transcriptional factors that are critical for the production of type I IFNs, including IRF1, IRF3, and IRF7, resulting in decr

• br Plasmid construction br The plasmid for expressing EGFP

  2019-10-07

  

  2.2. Plasmid construction The plasmid for expressing EGFP under a human survivin promoter (Psurvivin-EGFP) was constructed by replacing the human cytomega-lovirus (CMV) promoter in PEGFP-N3 (Takara Bio USA, Mountain View, CA) with the survivin promoter fragment. The human survivin pro-moter fra

167 records 9/12 page Previous Next First page Previous 5 pages 678910 Next 5 pages Last page